Cargando…
Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium
BACKGROUND: The molecular biology and cellular origins of mixed type endometrial carcinomas (MT-ECs) are poorly understood, and a Type II component of 10 percent or less may confer poorer prognoses. METHODOLOGY/PRINCIPAL FINDINGS: We studied 10 cases of MT-EC (containing endometrioid and serous diff...
Autores principales: | Lawrenson, Kate, Pakzamir, Elham, Liu, Biao, Lee, Janet M., Delgado, Melissa K., Duncan, Kara, Gayther, Simon A., Liu, Song, Roman, Lynda, Mhawech-Fauceglia, Paulette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488511/ https://www.ncbi.nlm.nih.gov/pubmed/26132201 http://dx.doi.org/10.1371/journal.pone.0130909 |
Ejemplares similares
-
Targeting Src in endometriosis-associated ovarian cancer
por: Manek, R, et al.
Publicado: (2016) -
Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2011) -
Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor
por: Kim, Grace, et al.
Publicado: (2015) -
Paratubal serous borderline tumor in an 85 years old woman: A case report
por: Mehawej, Jordy, et al.
Publicado: (2020) -
Bilateral Ovarian Serous Borderline Tumor with Non-Invasive Endometrial Implants
por: Malham, Melissa Bou, et al.
Publicado: (2023)